BridgeBio Pharma Inc. (BBIO)
NASDAQ: BBIO
· Real-Time Price · USD
51.30
0.12 (0.23%)
At close: Aug 15, 2025, 3:59 PM
51.00
-0.58%
After-hours: Aug 15, 2025, 07:58 PM EDT
BridgeBio Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 235.81M | 127.42M | 221.9M | 217.76M | 219.12M | 218.6M | 9.3M | 9.43M | 5.67M | 77.78M | 77.65M | 88.66M | 90.67M | 70.95M | 69.72M | 56.95M | 62.73M | 8.71M |
Cost of Revenue | 7.56M | 3.88M | 5.17M | 3.69M | 3.69M | 3.69M | 2.45M | 2.5M | 2.64M | 2.74M | 3.43M | 4.34M | 5.05M | 4.46M | 3.11M | 1.56M | 109K | n/a |
Gross Profit | 228.25M | 123.53M | 216.73M | 214.08M | 215.44M | 214.91M | 6.86M | 6.93M | 3.04M | 75.04M | 74.21M | 84.33M | 85.62M | 66.49M | 66.6M | 55.39M | 62.63M | 8.71M |
Operating Income | -655.62M | -697.69M | -589.57M | -540.96M | -506.9M | -477.46M | -607.37M | -552.14M | -523.57M | -351.35M | -376.2M | -419.63M | -440.01M | -560.14M | -576.63M | -538.51M | -508.95M | -539.5M |
Interest Income | 17.26M | 18.56M | 17.25M | 18.14M | 18.64M | 17.96M | 18.04M | 16.55M | 15.18M | 11.43M | 7.54M | 3.63M | 1.45M | 1.01M | 1.13M | 1.4M | 1.86M | 2.47M |
Pretax Income | -779.57M | -673.46M | -542.19M | -446.29M | -459.03M | -544.19M | -650.76M | -621M | -584.2M | -426.05M | -484.65M | -496.36M | -517.19M | -616.7M | -586.45M | -569.2M | -538.35M | -572.49M |
Net Income | -776.41M | -667.97M | -535.76M | -438.86M | -453.82M | -538.26M | -679.89M | -667.72M | -639.13M | -421.87M | -491.74M | -482.94M | -490.46M | -646.17M | -562.54M | -535.34M | -495.27M | -519.95M |
Selling & General & Admin | 398.5M | 329.49M | 287.63M | 240.44M | 207.39M | 183.99M | 150.59M | 134.87M | 130.28M | 130.58M | 143.19M | 166.08M | 180.97M | 190.52M | 192.21M | 174.9M | 164.83M | 156.83M |
Research & Development | 473.46M | 476.92M | 506.46M | 506.34M | 511.03M | 504.42M | 456.96M | 418.28M | 385.66M | 385.97M | 400.11M | 432.31M | 444.11M | 437.77M | 452.68M | 419.11M | 406.85M | 391.38M |
Other Expenses | 11.92M | 14.81M | 12.21M | 7.51M | 3.16M | 272K | -329K | -329K | -601K | -601K | n/a | n/a | -684K | -684K | -684K | -684K | 9K | 9K |
Operating Expenses | 883.88M | 821.22M | 806.3M | 754.28M | 721.59M | 688.69M | 607.82M | 553.42M | 515.94M | 516.56M | 543.3M | 598.39M | 625.08M | 628.29M | 644.89M | 594M | 571.68M | 548.21M |
Interest Expense | 132.66M | 117.96M | 99.29M | 89.74M | 86.98M | 84.64M | 81.29M | 81.01M | 80.53M | 80.22M | 80.44M | 75.58M | 66.82M | 57.38M | 46.78M | 42.61M | 42.47M | 42.38M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.34M | 9.34M | 9.34M | 9.34M | n/a | n/a | n/a |
Cost & Expenses | 891.43M | 825.1M | 811.48M | 757.97M | 725.27M | 691.78M | 609.02M | 554.02M | 516.68M | 518M | 546.09M | 601.17M | 628.58M | 631.09M | 646.35M | 595.46M | 571.68M | 548.21M |
Income Tax Expense | 5.44M | 3.34M | 209K | -944K | -2.58M | -2.58M | 32.48M | 47.88M | 57.74M | -4.18M | 7.08M | -8.32M | -16.54M | 45.38M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 190.52M | 190.15M | 189.44M | 188.51M | 187.59M | 178.71M | 174.46M | 163.31M | 160.54M | 152.65M | 149.34M | 147.94M | 146.68M | 145.88M | 145.28M | 146.66M | 146.75M | 138.63M |
Shares Outstanding (Diluted) | 190.52M | 190.15M | 189.44M | 188.51M | 187.59M | 178.71M | 174.46M | 163.31M | 160.54M | 152.65M | 149.34M | 147.94M | 146.68M | 145.88M | 145.28M | 146.66M | 146.75M | 138.63M |
EPS (Basic) | -4.09 | -3.53 | -2.85 | -2.41 | -2.63 | -3.22 | -4.18 | -4.26 | -4.18 | -2.8 | -3.33 | -3.3 | -3.36 | -4.42 | -3.91 | -3.91 | -3.83 | -4.2 |
EPS (Diluted) | -4.09 | -3.53 | -2.85 | -2.41 | -2.63 | -3.22 | -4.18 | -4.26 | -4.18 | -2.8 | -3.33 | -3.3 | -3.36 | -4.42 | -3.91 | -3.91 | -3.83 | -4.2 |
EBITDA | -643.59M | -551.92M | -436.83M | -350.26M | -368.14M | -455.58M | -565.47M | -535.91M | -497.09M | -428.82M | -486.94M | -505.2M | -536.16M | -554.51M | -535.38M | -522.63M | -492.18M | -528.2M |
EBIT | -649.1M | -557.68M | -426.47M | -340.12M | -358.11M | -445.61M | -571.96M | -542.48M | -503.67M | -345.84M | -404.21M | -422.33M | -451.91M | -560.87M | -541.23M | -526.94M | -496.23M | -530.46M |
Depreciation & Amortization | 5.51M | 5.76M | 6.08M | 6.29M | 6.39M | 6.46M | 6.49M | 6.57M | 6.58M | 6.52M | 6.77M | 6.64M | 5.26M | 6.36M | 5.84M | 4.75M | 3.47M | 2.28M |